Real-world anticoagulant use and clinical outcomes in postoperative atrial fibrillation after coronary artery bypass grafting: a nationwide practice-based cohort from The Netherlands Heart Registration
Among POAF patients after CABG, crude mortality was lower in OAC users, but no survival benefit was observed from 30 days onward. Low long-term OAC continuation without excess thromboembolic mortality suggests the potential value of time-limited anticoagulation strategies.
Authors
- Luuk Otterspoor (ORCID: https://orcid.org/0000-0002-8510-8648)
- Linda M. de Heer (ORCID: https://orcid.org/0000-0003-4815-8715)
- Mileen R. D. van de Kar (ORCID: https://orcid.org/0000-0001-9380-9404)
- Edgar J. Daeter (ORCID: https://orcid.org/0000-0002-6663-7974)
- Thomas J. van Brakel (ORCID: https://orcid.org/0000-0001-6933-1797)
- Saskia Houterman (ORCID: https://orcid.org/0000-0002-8680-1380)
- Marcel van ’t Veer (ORCID: https://orcid.org/0000-0002-5006-0111)
- Dennis van Veghel (ORCID: https://orcid.org/0000-0001-6108-9203)
- Harry J.G.M. Crijns (ORCID: https://orcid.org/0000-0003-1073-5337)
- Lukas Dekker (ORCID: https://orcid.org/0000-0002-8166-3716)
Institutions
- Radboud University Nijmegen (NL)
- Maastricht University Medical Centre (NL)
- Catharina Ziekenhuis (NL)
- University Medical Center Utrecht (NL)
- Maastricht University (NL)
- St. Antonius Ziekenhuis (NL)
- Netherlands Heart Registration (NL)
- Eindhoven University of Technology (NL)
Publication Details
- Journal
- European Heart Journal - Quality of Care and Clinical Outcomes
- Published
- 2025-10-18
- DOI
- https://doi.org/10.1093/ehjqcco/qcaf124
- Citations
- 2
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.78